Le indicates that she began receiving Depo-Provera injections in 1996, when she was 20 years old. She continued receiving regular injections until 2005, totaling about 40 shots in all, including both the name brand and generic versions.
After developing severe headaches, migraines, weakness in her limbs and memory loss, Le was diagnosed with an intracranial meningioma in 2010, and had surgery to have it removed.
The lawsuit indicates doctors removed a “golf ball” sized brain tumor from her head. However, the tumor returned in 2021. As a result, the lawsuit indicates that she has missed approximately 12 weeks of work, and has been left with continuing injuries
Le states that she did not discover the link between Depo-Provera and brain tumors until recently, since the manufacturers intentionally hid the risks from the public and the medical community.
“Plaintiff was unaware that her Depo-Provera use had any connection to her meningioma until the large case control study in France, which was published in March 2024, attracted publicity and became broadly known,” Le indicates in the lawsuit. “Had Plaintiff known Depo-Provera’s unreasonably dangerous characteristics, including that it caused hormone-sensitive tumors such as meningiomas, Plaintiff would never have consented to use the Depo-Provera. Plaintiff would instead have used other safer alternative forms of birth control that were in existence and available on the market.”
Her lawsuit presents claims of strict liability, including failure to warn and design defect, negligent failure to warn and design, general negligence, negligent misrepresentation, as well as fraud for intentional misrepresentation, violation of consumer protection laws and breach of warranty.